Abbott Laboratories’ latest head-to-head data of its Amplatzer Amulet heart device and Boston Scientific’s Watchman show more mixed results in safety metrics for the competing products.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,